한글목차

세계의 신경독 시장은 2019년 52억 9,089만 달러로 평가되었으며, 2024년까지 6.00% 이상의 복합 연간 성장률(CAGR)을 나타냈습니다.

신경 질환의 유병률 상승

신경질환의 유병률 증가는 실적 기간 동안 신경독 시장 성장을 견인했습니다. 신경 장애는 뇌, 척수, 신경에 영향을 미치고 다양한 신체적,인지적, 행동적 장애를 일으키는 병리입니다. 신경병증은 인구 고령화, 당뇨병과 같은 만성 질환 증가, 오염과 같은 환경 요인, COVID-19와 같은 감염의 장기적인 영향으로 세계적으로 증가하고 있습니다. 신경독 치료는 비정상적인 신경 활동을 선택적으로 표적으로 하여 차단함으로써 신경 장애를 돕고, 만성 편두통, 경련, 특정 운동 장애와 같은 증상에 치료적 완화를 제공하여 근육 통제를 개선하고 증상을 완화합니다. 예를 들어, 2024년 7월 미국에 본사를 둔 비영리 단체인 American Brain Foundation에 따르면 2021년 신경질환으로 인한 사망자 수는 1,110만명에 이르러 세계 인구의 43.1%에 해당하는 34억명이 영향을 받았습니다. 게다가 2022년 4월, 벨기에에 본사를 둔 비영리 단체인 European Brain Council에 따르면, 600개가 넘는 신경질환과 300명의 정신질환을 세계 수백만 명이 앓았습니다. 따라서 신경질환의 유병률 상승은 신경독 시장 성장을 가속하고 있습니다.

목차

제1장 주요 요약

• 신경독 - 시장 매력과 거시 경제 상황

제2장 목차

제3장 표 일람

제4장 그림 일람

제5장 보고서 구성

제6장 시장 특징

• 일반적인 시장 정의
• 개요
• 신경독 시장 정의와 세분화
• 제품 유형별 시장 세분화
  • 보톡스
  • 디스포트
  • 제오민
  • 기타 제품
• 시장 세분화 : 용도별
  • 치료
  • 미적
  • 기타 용도
• 시장 세분화 : 최종 사용자별
  • 병원
  • 전문 클리닉
  • 피부과 클리닉
  • 기타 최종 사용자

제7장 주요 시장 동향

• 치료 및 미용 용도 확대에 관한 규제 당국의 승인
• 신제품의 발매에 주력
• 혁신적인 효능과 용도의 확대
• 시장기업간의 전략적 파트너십 및 협업
• 혁신적인 신경독의 개발

제8장 세계의 신경독 성장 분석과 전략 분석 프레임워크

• 세계의 신경독 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인)
  • 정치
  • 경제
  • 사회
  • 기술
  • 환경
  • 법률
• 최종 사용자 산업(B2B) 분석
  • 병원
  • 전문 클리닉
  • 피부과 클리닉
  • 기타 최종 사용자
• 세계의 신경독 시장 : 성장률 분석
• 시장 성장 실적(2019-2024년)
  • 시장 성장 촉진요인(2019-2024년)
  • 시장 성장 억제요인(2019-2024년)
• 시장 성장 예측(2024-2029년, 2034년)
• 성장 예측의 공헌 요인
  • 양적 성장의 공헌자
  • 성장 촉진요인
  • 성장 억제요인
• 세계의 신경독물 전체 시장(TAM)

제9장 세계의 신경독 시장 : 세분화

• 세계의 신경독 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 신경독 시장 : 용도별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 신경독 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 신경독 시장 : 보톡스 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 신경독 시장 : 디스포트 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 신경독 시장 : 제오민 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 신경독 시장 : 기타 제품 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)

제10장 신경독시장 : 지역 및 국가별 분석

• 세계의 신경독 시장 : 지역별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 신경독 시장 : 국가별, 분석과 예측(2019-2024년, 2029년, 2034년)

제11장 아시아태평양 시장

제12장 서유럽 시장

제13장 동유럽 시장

제14장 북미 시장

제15장 남미 시장

제16장 중동 시장

제17장 아프리카 시장

제18장 경쟁 구도와 기업 프로파일

• 기업 프로파일
• Abbvie Inc.
• Merz Pharma GmbH & Co. KGaA
• Ipsen Pharma SA
• Evolus Inc.
• Revance Therapeutics Inc.

제19장 기타 주요 기업 및 혁신 기업

• Daewoong Pharmaceutical Co. Ltd.
• Galderma SA
• Sinclair Pharma plc
• Croma - Pharma GmbH
• Supernus Pharmaceuticals Inc.
• Alphaeon Corporation
• Hugel Inc.
• Entod Pharmaceuticals Ltd.
• Aquavit Pharmaceuticals Inc.
• Object Pharma Inc.
• Biotium Inc.
• Vida Aesthetics Ltd.
• Medytox Inc.
• Gufic Biosciences Ltd.
• AEON Biopharma

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병(M&A)

• Crown Laboratories, Revance Therapeutics 인수
• Priveterra Acquisition Corp. AEON Biopharma Inc. 인수

제23장 신경독 시장 최근 동향

제24장 기회와 전략

• 세계의 신경독 시장(2029년) : 새로운 기회를 제공하는 국가
• 세계의 신경독 시장(2029년) : 새로운 기회를 제공하는 부문
• 세계의 신경독 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제25장 신경독시장 : 결론과 제안

• 결론
• 권고
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

영문목차

Neurotoxins refer to a class of biological or synthetic substances that adversely affect the structure or function of the nervous system by disrupting neural transmission, damaging nerve cells, or altering neurotransmitter activity.

The neurotoxin market consists of sales, by entities (organizations, sole traders or partnerships), of neurotoxin naturally derived, such as botulinum toxin from clostridium botulinum, or synthetically engineered for therapeutic applications. While certain neurotoxins pose environmental and biological hazards, others are used in controlled doses for medical and cosmetic purposes. In healthcare, purified neurotoxins are primarily used to treat a range of neuromuscular and neurological disorders, including chronic migraine, cervical dystonia, spasticity and hyperhidrosis, as well as for aesthetic treatments to reduce facial wrinkles.

The global neurotoxin market was valued at $5,290.89 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Prevalence Of Neurological Disorders

The rising prevalence of neurological disorders drove the growth of the neurotoxin market during historic period. Neurological disorders are medical conditions that affect the brain, spinal cord, or nerves, leading to a range of physical, cognitive, or behavioral impairments. Neurological disorders are increasing globally due to aging populations, rising chronic diseases like diabetes, environmental factors such as pollution and the long-term effects of infections like COVID-19. Neurotoxin treatments help neurological disorders by selectively targeting and blocking abnormal nerve activity, providing therapeutic relief for conditions such as chronic migraines, spasticity and certain movement disorders, thereby improving muscle control and reducing symptoms. For instance, in July 2024, according to the American Brain Foundation, a US-based non-profit organization, in 2021, neurological disorders accounted for 11.1 million fatalities and impacted 3.4 billion people, or 43.1% of the world's population. Moreover, in April 2022, according to the European Brain Council, a Belgium-based non-profit organization, over 600 neurological diseases and nearly 300 psychiatric conditions afflict millions globally. Therefore, the rising prevalence of neurological disorders is driving the growth of the neurotoxin market.

Focus On Launch Of New Products

Major companies operating in the neurotoxin market are focusing on launching new products to strengthen their market presence. Product launch is the introduction of a new product or service into the marketplace, accompanied by a series of strategic marketing, distribution, and sales activities aimed at generating awareness, interest, and initial adoption. For example, in September 2024, Allergan Aesthetics, an AbbVie company, launched BOTOX Cosmetic (onabotulinumtoxinA) in China for the treatment of masseter muscle prominence (MMP) in adults. This approval by the China National Medical Product Administration (NMPA) makes BOTOX(R) Cosmetic the first neurotoxin approved in China for this indication. MMP is characterized by an enlarged masseter muscle, leading to a wider, square-shaped lower face, which can be an aesthetic concern for some individuals. The condition may result from genetic factors or activities such as excessive chewing or teeth grinding. Clinical trials demonstrated that treatment with BOTOX(R) Cosmetic resulted in an average reduction of facial width by 5.2mm compared to placebo, with effects typically lasting between six to nine months.

The global neurotoxin markets are highly concentrated, with large players operating in the market. The top 10 competitors in the market made up 68.52% of the total market in 2024.

Neurotoxin Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global neurotoxin market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for neurotoxin? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider neurotoxin market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by application and by end user.
• Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the unmanned underwater vehicles market.
• Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product type, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for neurotoxin market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product Type: Botox; Dysport; Xeomin; Other products
• 2) By Application: Therapeutic; Aesthetic; Other Applications
• 3) By End-User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Companies Mentioned: Abbvie Inc.; Merz Pharma GmbH & Co. KGaA; Ipsen Pharma SA; Evolus Inc.; Revance Therapeutics Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; neurotoxin indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Neurotoxin - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Neurotoxin Market Definition And Segmentations
• 6.4 Market Segmentation By Product Type
  • 6.4.1 Botox
  • 6.4.2 Dysport
  • 6.4.3 Xeomin
  • 6.4.4 Other Products
• 6.5 Market Segmentation By Application
  • 6.5.1 Therapeutic
  • 6.5.2 Aesthetic
  • 6.5.3 Other Applications
• 6.6 Market Segmentation By End User
  • 6.6.1 Hospitals
  • 6.6.2 Specialty Clinics
  • 6.6.3 Dermatology Clinics
  • 6.6.4 Other End Users

7 Major Market Trends

• 7.1 Regulatory Approvals For Expansion Of Therapeutic And Aesthetic Applications
• 7.2 Focus On Launch Of New Products
• 7.3 Innovating Efficacy And Expanding Applications
• 7.4 Strategic Partnerships And Collaborations Among Market Players
• 7.5 Innovative Neurotoxin Developments

8 Global Neurotoxin Growth Analysis And Strategic Analysis Framework

• 8.1 Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End User Industries (B2B)
  • 8.2.1 Hospitals
  • 8.2.2 Specialty Clinics
  • 8.2.3 Dermatology Clinics
  • 8.2.4 Other End Users
• 8.3 Global Neurotoxin Market Growth Rate Analysis
• 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 8.4.1 Market Drivers 2019 - 2024
  • 8.4.2 Market Restraints 2019 - 2024
• 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Global Neurotoxin Total Addressable Market (TAM)

9 Global Neurotoxin Market Segmentation

• 9.1 Global Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.2 Global Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.3 Global Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.4 Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.5 Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.6 Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.7 Global Neurotoxin Market, Sub-Segmentation By Other Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Neurotoxin Market, Regional and Country Analysis

• 10.1 Global Neurotoxin Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Global Neurotoxin Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.4 Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.5 Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.6 Asia-Pacific Neurotoxin Market: Country Analysis
• 11.7 China Market
• 11.8 Summary
• 11.9 Market Overview
  • 11.9.1 Country Information
  • 11.9.2 Market Information
  • 11.9.3 Background Information
  • 11.9.4 Government Initiatives
  • 11.9.5 Regulations
  • 11.9.6 Regulatory Bodies
  • 11.9.7 Major Associations
  • 11.9.8 Taxes Levied
  • 11.9.9 Corporate Tax Structure
  • 11.9.10 Investments
  • 11.9.11 Major Companies
• 11.10 China Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.11 China Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.12 China Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.13 India Market
• 11.14 India Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.15 India Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.16 India Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.17 Japan Market
• 11.18 Summary
• 11.19 Market Overview
  • 11.19.1 Country Information
  • 11.19.2 Market Information
  • 11.19.3 Background Information
  • 11.19.4 Government Initiatives
  • 11.19.5 Regulations
  • 11.19.6 Regulatory Bodies
  • 11.19.7 Major Associations
  • 11.19.8 Taxes Levied
  • 11.19.9 Corporate Tax Structure
  • 11.19.10 Investments
  • 11.19.11 Major Companies
• 11.20 Japan Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.21 Japan Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.22 Japan Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.23 South Korea Market
• 11.24 Summary
• 11.25 Market Overview
  • 11.25.1 Country Information
  • 11.25.2 Market Information
  • 11.25.3 Background Information
  • 11.25.4 Government Initiatives
  • 11.25.5 Regulations
  • 11.25.6 Regulatory Bodies
  • 11.25.7 Major Associations
  • 11.25.8 Taxes Levied
  • 11.25.9 Corporate Tax Structure
  • 11.25.10 Investments
  • 11.25.11 Major Companies
• 11.26 South Korea Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.27 South Korea Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.28 South Korea Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.29 Australia Market
• 11.30 Australia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.31 Australia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.32 Australia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.33 Indonesia Market
• 11.34 Indonesia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.35 Indonesia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.36 Indonesia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate tax structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Western Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Western Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Western Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.6 Western Europe Neurotoxin Market: Country Analysis
• 12.7 UK Market
• 12.8 UK Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.9 UK Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 UK Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.11 Germany Market
• 12.12 Germany Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 Germany Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 Germany Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.15 France Market
• 12.16 France Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 France Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 France Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.19 Italy Market
• 12.20 Italy Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.21 Italy Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 Italy Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.23 Spain Market
• 12.24 Spain Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 Spain Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.26 Spain Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Major Companies
• 13.3 Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Eastern Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Eastern Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.6 Russia Market
• 13.7 Russia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.8 Russia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.9 Russia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 North America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 North America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.6 North America Neurotoxin Market: Country Analysis
• 14.7 USA Market
• 14.8 Summary
• 14.9 Market Overview
  • 14.9.1 Country Information
  • 14.9.2 Market Information
  • 14.9.3 Background Information
  • 14.9.4 Government Initiatives
  • 14.9.5 Regulations
  • 14.9.6 Regulatory Bodies
  • 14.9.7 Major Associations
  • 14.9.8 Taxes Levied
  • 14.9.9 Corporate Tax Structure
  • 14.9.10 Investments
  • 14.9.11 Major Companies
• 14.10 USA Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.11 USA Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.12 USA Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.13 Canada Market
• 14.14 Summary
• 14.15 Market Overview
  • 14.15.1 Country Information
  • 14.15.2 Market Information
  • 14.15.3 Background Information
  • 14.15.4 Government Initiatives
  • 14.15.5 Regulations
  • 14.15.6 Regulatory Bodies
  • 14.15.7 Major Associations
  • 14.15.8 Taxes Levied
  • 14.15.9 Corporate Tax Structure
  • 14.15.10 Investments
  • 14.15.11 Major Companies
• 14.16 Canada Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.17 Canada Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.18 Canada Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulation
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 South America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 South America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 South America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.6 Brazil Market
• 15.7 Brazil Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.8 Brazil Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.9 Brazil Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 Middle East Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 Middle East Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 Middle East Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Africa Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Africa Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.5 Africa Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Abbvie Inc.
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Business Strategy
  • 18.2.4 Financial Overview
• 18.3 Merz Pharma GmbH & Co. KGaA
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Financial Overview
• 18.4 Ipsen Pharma SA
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Business Strategy
  • 18.4.4 Financial Overview
• 18.5 Evolus Inc.
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Business Strategy
  • 18.5.4 Financial Overview
• 18.6 Revance Therapeutics Inc.
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Business Strategy
  • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

• 19.1 Daewoong Pharmaceutical Co. Ltd.
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 Galderma S.A.
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 Sinclair Pharma plc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 Croma-Pharma GmbH
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Supernus Pharmaceuticals Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
• 19.6 Alphaeon Corporation
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
• 19.7 Hugel Inc.
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
• 19.8 Entod Pharmaceuticals Ltd.
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
• 19.9 Aquavit Pharmaceuticals Inc.
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
• 19.10 Object Pharma Inc.
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
• 19.11 Biotium Inc.
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
• 19.12 Vida Aesthetics Ltd.
  • 19.12.1 Company Overview
  • 19.12.2 Products And Services
• 19.13 Medytox Inc.
  • 19.13.1 Company Overview
  • 19.13.2 Products And Services
• 19.14 Gufic Biosciences Ltd.
  • 19.14.1 Company Overview
  • 19.14.2 Products And Services
• 19.15 AEON Biopharma
  • 19.15.1 Company Overview
  • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Crown Laboratories Acquired Revance Therapeutics
• 22.2 Priveterra Acquisition Corp. Acquired AEON Biopharma Inc.

23 Recent Developments In The Neurotoxin Market

• 23.1 Daewoong Pharmaceutical Introduces NABOTA To Saudi Arabia's Expanding Aesthetic Market
• 23.2 Oxapharma Launches Clodew As A Breakthrough Toxin For Targeted Therapeutic Treatments
• 23.3 Godrej Consumer Products Launches Formaldehyde-Free Botosmooth Hair Botox Treatment in Maharashtra

24 Opportunities And Strategies

• 24.1 Global Neurotoxin Market In 2029 - Countries Offering Most New Opportunities
• 24.2 Global Neurotoxin Market In 2029 - Segments Offering Most New Opportunities
• 24.3 Global Neurotoxin Market In 2029 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Neurotoxin Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer